Philadelphia Pharmaceuticals Company (ASE:PHIL)
2.300
+0.150 (6.98%)
At close: Nov 10, 2026
ASE:PHIL Revenue
Philadelphia Pharmaceuticals Company had revenue of 2.47M JOD in the quarter ending September 30, 2026, with 18.96% growth. This brings the company's total for the last twelve months to 9.37M, up 2.78% year-over-year. In the year 2025, Philadelphia Pharmaceuticals Company had annual revenue of 9.17M with 4.64% growth. That makes Philadelphia Pharmaceuticals Company the 36,099th largest company in the world by revenue and 78th in Jordan.
Revenue (ttm)
9.37M
Revenue Growth
+2.78%
P/S Ratio
1.84
Revenue / Employee
72.61K
Employees
129
Market Cap
17.25M
Revenue by Geography
- Jordan 4.77M 52.0%
- Export 4.40M 48.0%
Fiscal year ended Dec 31, 2025 See the full ASE:PHIL breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.17M | 406.53K | 4.64% |
| Dec 31, 2024 | 8.76M | 357.51K | 4.25% |
| Dec 31, 2023 | 8.40M | -10.46K | -0.12% |
| Dec 31, 2022 | 8.42M | 1.81M | 27.48% |
| Dec 31, 2021 | 6.60M | -1.05M | -13.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.